Cargando…

The Spinal Cord as Organ of Risk: Assessment for Acute and Subacute Neurological Adverse Effects after Microbeam Radiotherapy in a Rodent Model

SIMPLE SUMMARY: Organs which receive an irradiation dose because they are located in the vicinity of the irradiation target are considered organs of risk. Before a new irradiation technique is tested in clinical trials, it is important to make an assessment of the potential adverse effects in these...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaekel, Felix, Paino, Jason, Engels, Elette, Klein, Mitzi, Barnes, Micah, Häusermann, Daniel, Hall, Christopher, Zheng, Gang, Wang, Hongxin, Hildebrandt, Guido, Lerch, Michael, Schültke, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177263/
https://www.ncbi.nlm.nih.gov/pubmed/37173938
http://dx.doi.org/10.3390/cancers15092470
_version_ 1785040597305786368
author Jaekel, Felix
Paino, Jason
Engels, Elette
Klein, Mitzi
Barnes, Micah
Häusermann, Daniel
Hall, Christopher
Zheng, Gang
Wang, Hongxin
Hildebrandt, Guido
Lerch, Michael
Schültke, Elisabeth
author_facet Jaekel, Felix
Paino, Jason
Engels, Elette
Klein, Mitzi
Barnes, Micah
Häusermann, Daniel
Hall, Christopher
Zheng, Gang
Wang, Hongxin
Hildebrandt, Guido
Lerch, Michael
Schültke, Elisabeth
author_sort Jaekel, Felix
collection PubMed
description SIMPLE SUMMARY: Organs which receive an irradiation dose because they are located in the vicinity of the irradiation target are considered organs of risk. Before a new irradiation technique is tested in clinical trials, it is important to make an assessment of the potential adverse effects in these organs of risk. Microbeam radiotherapy is an innovative radiotherapy technique suitable to control tumours which are considered radioresistant with conventional, already clinically established irradiation techniques. In a small animal model, we have conducted a risk assessment in the thoracic spinal cord as organ of risk during microbeam irradiation in the thoracic cavity and determined the upper dose limit beyond which neurological signs of temporary or permanent damage occur. ABSTRACT: Microbeam radiotherapy (MRT), a high dose rate radiotherapy technique using spatial dose fractionation at the micrometre range, has shown a high therapeutic efficacy in vivo in different tumour entities, including lung cancer. We have conducted a toxicity study for the spinal cord as organ of risk during irradiation of a target in the thoracic cavity. In young adult rats, the lower thoracic spinal cord was irradiated over a length of 2 cm with an array of quasi-parallel microbeams of 50 µm width, spaced at a centre-to-centre distance of 400 µm, with MRT peak doses up to 800 Gy. No acute or subacute adverse effects were observed within the first week after irradiation up to MRT peak doses of 400 Gy. No significant differences were seen between irradiated animals and non-irradiated controls in motor function and sensitivity, open field test and somatosensory evoked potentials (SSEP). After irradiation with MRT peak doses of 450–800 Gy, dose-dependent neurologic signs occurred. Provided that long-term studies do not reveal significant morbidity due to late toxicity, an MRT dose of 400 Gy can be considered safe for the spinal cord in the tested beam geometry and field size.
format Online
Article
Text
id pubmed-10177263
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101772632023-05-13 The Spinal Cord as Organ of Risk: Assessment for Acute and Subacute Neurological Adverse Effects after Microbeam Radiotherapy in a Rodent Model Jaekel, Felix Paino, Jason Engels, Elette Klein, Mitzi Barnes, Micah Häusermann, Daniel Hall, Christopher Zheng, Gang Wang, Hongxin Hildebrandt, Guido Lerch, Michael Schültke, Elisabeth Cancers (Basel) Article SIMPLE SUMMARY: Organs which receive an irradiation dose because they are located in the vicinity of the irradiation target are considered organs of risk. Before a new irradiation technique is tested in clinical trials, it is important to make an assessment of the potential adverse effects in these organs of risk. Microbeam radiotherapy is an innovative radiotherapy technique suitable to control tumours which are considered radioresistant with conventional, already clinically established irradiation techniques. In a small animal model, we have conducted a risk assessment in the thoracic spinal cord as organ of risk during microbeam irradiation in the thoracic cavity and determined the upper dose limit beyond which neurological signs of temporary or permanent damage occur. ABSTRACT: Microbeam radiotherapy (MRT), a high dose rate radiotherapy technique using spatial dose fractionation at the micrometre range, has shown a high therapeutic efficacy in vivo in different tumour entities, including lung cancer. We have conducted a toxicity study for the spinal cord as organ of risk during irradiation of a target in the thoracic cavity. In young adult rats, the lower thoracic spinal cord was irradiated over a length of 2 cm with an array of quasi-parallel microbeams of 50 µm width, spaced at a centre-to-centre distance of 400 µm, with MRT peak doses up to 800 Gy. No acute or subacute adverse effects were observed within the first week after irradiation up to MRT peak doses of 400 Gy. No significant differences were seen between irradiated animals and non-irradiated controls in motor function and sensitivity, open field test and somatosensory evoked potentials (SSEP). After irradiation with MRT peak doses of 450–800 Gy, dose-dependent neurologic signs occurred. Provided that long-term studies do not reveal significant morbidity due to late toxicity, an MRT dose of 400 Gy can be considered safe for the spinal cord in the tested beam geometry and field size. MDPI 2023-04-26 /pmc/articles/PMC10177263/ /pubmed/37173938 http://dx.doi.org/10.3390/cancers15092470 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jaekel, Felix
Paino, Jason
Engels, Elette
Klein, Mitzi
Barnes, Micah
Häusermann, Daniel
Hall, Christopher
Zheng, Gang
Wang, Hongxin
Hildebrandt, Guido
Lerch, Michael
Schültke, Elisabeth
The Spinal Cord as Organ of Risk: Assessment for Acute and Subacute Neurological Adverse Effects after Microbeam Radiotherapy in a Rodent Model
title The Spinal Cord as Organ of Risk: Assessment for Acute and Subacute Neurological Adverse Effects after Microbeam Radiotherapy in a Rodent Model
title_full The Spinal Cord as Organ of Risk: Assessment for Acute and Subacute Neurological Adverse Effects after Microbeam Radiotherapy in a Rodent Model
title_fullStr The Spinal Cord as Organ of Risk: Assessment for Acute and Subacute Neurological Adverse Effects after Microbeam Radiotherapy in a Rodent Model
title_full_unstemmed The Spinal Cord as Organ of Risk: Assessment for Acute and Subacute Neurological Adverse Effects after Microbeam Radiotherapy in a Rodent Model
title_short The Spinal Cord as Organ of Risk: Assessment for Acute and Subacute Neurological Adverse Effects after Microbeam Radiotherapy in a Rodent Model
title_sort spinal cord as organ of risk: assessment for acute and subacute neurological adverse effects after microbeam radiotherapy in a rodent model
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177263/
https://www.ncbi.nlm.nih.gov/pubmed/37173938
http://dx.doi.org/10.3390/cancers15092470
work_keys_str_mv AT jaekelfelix thespinalcordasorganofriskassessmentforacuteandsubacuteneurologicaladverseeffectsaftermicrobeamradiotherapyinarodentmodel
AT painojason thespinalcordasorganofriskassessmentforacuteandsubacuteneurologicaladverseeffectsaftermicrobeamradiotherapyinarodentmodel
AT engelselette thespinalcordasorganofriskassessmentforacuteandsubacuteneurologicaladverseeffectsaftermicrobeamradiotherapyinarodentmodel
AT kleinmitzi thespinalcordasorganofriskassessmentforacuteandsubacuteneurologicaladverseeffectsaftermicrobeamradiotherapyinarodentmodel
AT barnesmicah thespinalcordasorganofriskassessmentforacuteandsubacuteneurologicaladverseeffectsaftermicrobeamradiotherapyinarodentmodel
AT hausermanndaniel thespinalcordasorganofriskassessmentforacuteandsubacuteneurologicaladverseeffectsaftermicrobeamradiotherapyinarodentmodel
AT hallchristopher thespinalcordasorganofriskassessmentforacuteandsubacuteneurologicaladverseeffectsaftermicrobeamradiotherapyinarodentmodel
AT zhenggang thespinalcordasorganofriskassessmentforacuteandsubacuteneurologicaladverseeffectsaftermicrobeamradiotherapyinarodentmodel
AT wanghongxin thespinalcordasorganofriskassessmentforacuteandsubacuteneurologicaladverseeffectsaftermicrobeamradiotherapyinarodentmodel
AT hildebrandtguido thespinalcordasorganofriskassessmentforacuteandsubacuteneurologicaladverseeffectsaftermicrobeamradiotherapyinarodentmodel
AT lerchmichael thespinalcordasorganofriskassessmentforacuteandsubacuteneurologicaladverseeffectsaftermicrobeamradiotherapyinarodentmodel
AT schultkeelisabeth thespinalcordasorganofriskassessmentforacuteandsubacuteneurologicaladverseeffectsaftermicrobeamradiotherapyinarodentmodel
AT jaekelfelix spinalcordasorganofriskassessmentforacuteandsubacuteneurologicaladverseeffectsaftermicrobeamradiotherapyinarodentmodel
AT painojason spinalcordasorganofriskassessmentforacuteandsubacuteneurologicaladverseeffectsaftermicrobeamradiotherapyinarodentmodel
AT engelselette spinalcordasorganofriskassessmentforacuteandsubacuteneurologicaladverseeffectsaftermicrobeamradiotherapyinarodentmodel
AT kleinmitzi spinalcordasorganofriskassessmentforacuteandsubacuteneurologicaladverseeffectsaftermicrobeamradiotherapyinarodentmodel
AT barnesmicah spinalcordasorganofriskassessmentforacuteandsubacuteneurologicaladverseeffectsaftermicrobeamradiotherapyinarodentmodel
AT hausermanndaniel spinalcordasorganofriskassessmentforacuteandsubacuteneurologicaladverseeffectsaftermicrobeamradiotherapyinarodentmodel
AT hallchristopher spinalcordasorganofriskassessmentforacuteandsubacuteneurologicaladverseeffectsaftermicrobeamradiotherapyinarodentmodel
AT zhenggang spinalcordasorganofriskassessmentforacuteandsubacuteneurologicaladverseeffectsaftermicrobeamradiotherapyinarodentmodel
AT wanghongxin spinalcordasorganofriskassessmentforacuteandsubacuteneurologicaladverseeffectsaftermicrobeamradiotherapyinarodentmodel
AT hildebrandtguido spinalcordasorganofriskassessmentforacuteandsubacuteneurologicaladverseeffectsaftermicrobeamradiotherapyinarodentmodel
AT lerchmichael spinalcordasorganofriskassessmentforacuteandsubacuteneurologicaladverseeffectsaftermicrobeamradiotherapyinarodentmodel
AT schultkeelisabeth spinalcordasorganofriskassessmentforacuteandsubacuteneurologicaladverseeffectsaftermicrobeamradiotherapyinarodentmodel